The Pennant Group, Inc.

NASDAQ:PNTG

Medical - Care Facilities

Healthcare
$35.81 -2.41%

-$0.83 today

Market cap
$1.26B
Beta
1.27
P/E (TTM)
38.6
EPS (TTM)
$0.87
52W Low $21.73High $37.54

Volume 0.43M

Average 0.25M

PNTG Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

The Pennant Group, Inc.NASDAQ: PNTG

Stock-Based Compensation · Q1 FY2026 · quarter ended Mar 2026

Stock-based compensation grows, but more slowly than its trailing trend

Q1 FY2026 stock-based compensation of $2.52M rose 17.4% year over year, behind the +60.6% change in trailing-twelve-month stock-based compensation. Sequentially, it fell 61.1% from the prior quarter. Over 3 fiscal years it compounded at +42.6% a year.

Context

  • Stock-based compensation amounted to 0.9% of revenue in FY2025, down 0.2 pp from a year earlier.
  • Stock-based compensation increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +17.4% toward the trailing-twelve-month pace of +60.6%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$2.52M-61.1% QoQ
Last fiscal yearDec 2025
$8.94M+14.9% YoY
LTMMar 2026
$13.63M+60.6% YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+17.4%——
1 year+14.9%——
3-year CAGR+42.6%——
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

USD · from the cash flow

Latest · FY2025
8.94M USD
Year-over-year change
+14.9%
4-year CAGR
-2.9%

Stock-Based Compensation vs competitors

How PNTG compares with its peers on the latest reported figures

  • PNTG's LTM Mar 2026 stock-based compensation of $13.63M is the 8th largest of the 11 companies compared; the peer median is $20.97M.
  • Its year-over-year change of +60.6% is the 3rd highest of 11, against a peer median of +34.9%.
  • Stock-based compensation amounts to 1.3% of revenue for PNTG, versus a peer median of 1.0%.
PNTG Competitors Peer median
Stock-Based Compensation for PNTG and competitors
Company Period LTM YoY 3-year CAGR% of revenue
PACSPACS Group, Inc.LTM Jun 2026$74.44M +47.7%—1.3%
EHCEncompass Health CorporationLTM Jun 2026$58M +17.9%—0.9%
ENSGThe Ensign Group, Inc.LTM Jun 2026$55.97M +35.2%+28.6%1.0%
BKDBrookdale Senior Living Inc.LTM Sep 2026$51.51M +289.2%-6.2%1.7%
ADUSAddus HomeCare CorporationLTM Jun 2026$23.22M +74.9%+15.6%1.6%
CHEChemed CorporationLTM Jun 2026$18.72M -42.3%-42.9%0.7%
AVAHAveanna Healthcare Holdings Inc.LTM Oct 2026$16.97M -165.0%—0.6%
PNTGThe Pennant Group, Inc.LTM Mar 2026$13.63M +60.6%+42.6%1.3%
SNDASonida Senior Living, Inc.LTM Mar 2026$6.47M +35.8%+5.3%1.6%
NHCNational HealthCare CorporationLTM Sep 2026$6.19M +34.5%+19.0%0.4%
INNVInnovAge Holding Corp.LTM Mar 2026$3.36M -56.6%+26.8%0.4%
Peer median (excluding PNTG) $20.97M+34.9%+15.6%1.0%

Competitors are the stored peer set for PNTG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income2.15M7.24M13.91M24.34M33.76M
Depreciation & Amortization4.78M4.9M5.13M6.12M8.54M
Deferred Income Tax(1.75M)1.7M4M(1.19M)(2.19M)
Stock-Based Compensation10.04M3.09M5.37M7.78M8.94M
Change in Working Capital(37.38M)(9.5M)3.44M929K(1.6M)
Accounts Receivables(7.34M)(361K)(7.35M)(21.09M)(24.15M)
Inventory00000
Accounts Payables562K2.37M(1.85M)8.05M5.8M
Other Working Capital(30.61M)(11.51M)12.64M13.97M16.75M
Other Non-Cash Items3.94M1.62M1.24M1.32M837K
Operating Cash Flow(18.22M)9.04M33.09M39.3M48.29M
Capital Expenditures(6.3M)(14.17M)(8.11M)(8.99M)(22M)
Acquisitions (Net)(13.55M)(10.13M)(21.38M)(48.42M)(204.02M)
Purchases of Investments0000(2.89M)
Sales of Investments00000
Other Investing Activities(267K)61K(741K)(13.28M)943K
Investing Cash Flow(20.12M)(24.24M)(30.22M)(70.68M)(227.97M)
Debt Repayment44M11M500K(65M)173.8M
Common Stock Issued01.08M579K119M552K
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(510K)1.08M33K(4.43M)(1.89M)
Financing Cash Flow43.49M12.08M1.11M49.57M172.46M
Effect of Forex Changes00000
Net Change in Cash5.15M(3.11M)3.98M18.19M(7.22M)
Free Cash Flow(24.53M)(5.13M)24.99M30.31M26.3M

The Pennant Group, Inc.

NASDAQ:PNTG

Intrinsic Alpha fair value

Locked

Current Price

$35.81

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.